| 000 | 01642 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250516200848.0 | ||
| 264 | 0 | _c20141125 | |
| 008 | 201411s 0 0 eng d | ||
| 022 | _a1873-3913 | ||
| 024 | 7 |
_a10.1016/j.cellsig.2014.02.006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChidiac, Peter | |
| 245 | 0 | 0 |
_aThe eIF2B-interacting domain of RGS2 protects against GPCR agonist-induced hypertrophy in neonatal rat cardiomyocytes. _h[electronic resource] |
| 260 |
_bCellular signalling _cJun 2014 |
||
| 300 |
_a1226-34 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAnimals, Newborn |
| 650 | 0 | 4 |
_aCardiomegaly _xmetabolism |
| 650 | 0 | 4 |
_aCell Size _xdrug effects |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aCyclic AMP _xmetabolism |
| 650 | 0 | 4 | _aEukaryotic Initiation Factor-2B |
| 650 | 0 | 4 | _aGene Expression |
| 650 | 0 | 4 |
_aInositol Phosphates _xmetabolism |
| 650 | 0 | 4 |
_aIsoproterenol _xpharmacology |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aPhenylephrine _xpharmacology |
| 650 | 0 | 4 | _aProtein Biosynthesis |
| 650 | 0 | 4 | _aProtein Interaction Domains and Motifs |
| 650 | 0 | 4 |
_aRGS Proteins _xchemistry |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 |
_aReceptors, G-Protein-Coupled _xagonists |
| 650 | 0 | 4 | _aSecond Messenger Systems |
| 700 | 1 | _aSobiesiak, Alina J | |
| 700 | 1 | _aLee, Katherine N | |
| 700 | 1 | _aGros, Robert | |
| 700 | 1 | _aNguyen, Chau H | |
| 773 | 0 |
_tCellular signalling _gvol. 26 _gno. 6 _gp. 1226-34 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cellsig.2014.02.006 _zAvailable from publisher's website |
| 999 |
_c23592297 _d23592297 |
||